Avanzanite Bioscience

Redefining the orphan drug landscape & unlocking energy for patients with rare diseases in Europe.

[Avanzanite Bioscience @AvanzaniteBio]

“Together with my colleagues in Germany and Europe, we have a great opportunity and mission to significantly improve the lives of people with rare diseases.” https://t.co/stC5osqABT
#innovation #orphandrugs #raredisease #dRTA #nephrology #pediatricnephrology #pediatrics #kidney

[Avanzanite Bioscience @AvanzaniteBio]

2023 Knights for Rare: The Acanthamoeba Keratitis Eye Foundation https://t.co/48s1sEgppV via @YouTube

#raredisease #AKeyefoundation

[Avanzanite Bioscience @AvanzaniteBio]

Today is #rarediseaseday and we are excited to share that we've partnered with #Advicenne in distal Renal Tubular Acidosis (#dRTA).

https://t.co/ydAlKNCSDS

#raredisease #patientsfirst #orphandrugs

[Adam Andrzej Plich @AdamPlich]

READ more about our partnership with SIFI in #acanthamoebakeratitis #RareDiseases #orphandrugs #innovation #patientsfirst
https://t.co/lZ9YN1YNoU

[Avanzanite Bioscience @AvanzaniteBio]

Read about our mission in the latest edition of @Biotech_finance which featured an interview with Founder & CEO @AdamPlich #orphandrugs #rarediseases #patientaccess #innovation

[SKC Consulting @consulting_skc]

Prof. Dr. Schönermark berichtet im Profcast über die drei dominierenden Themen des World Orphan Drug Congress Europe und führt live Interviews mit @AlexionPharma und @AvanzaniteBio. Jetzt reinhören unter https://t.co/uczhBx62aV. #WODC @orphan_drugs #orphandrugs #rarediseases

[Avanzanite Bioscience @AvanzaniteBio]

Avanzanite Bioscience looks to commercialize innovative medicines for rare diseases in Europe https://t.co/RafYsMpCi4 via @Labiotech_eu #rarediseases #orphandrugs #innovation

[Avanzanite Bioscience @AvanzaniteBio]

BRIEF—New business model to boost orphan drug access in Europe https://t.co/Jm9BDzEAZN

[Adam Andrzej Plich @AdamPlich]

Launching Avanzanite Bioscience Today – Find out WHY: https://t.co/sUrJmGWNAh
#orphandrugs #rarediseases #patientaccess
#innovation #corporatelaunch